Fungicidal Activity of the Nitroimidazole–Thiosemicarbazide Derivative 1-[(1-methyl-4-nitroimidazol-2-yl)carbonyl]-4-(3-methylophenyl)thiosemicarbazide Against Trichophyton spp. Dermatophytes
Pathogens · 30.06.2026 · 15 (7) · 688
DOI: 10.3390/pathogens15070688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 30.06.2026. Verfasst von Sylwia Andrzejczuk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Microbiology, Medical University of Lublin, Chodzki Str. 1, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Antifungal Agents, Semicarbazides, Trichophyton, Nitroimidazoles. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Medical University of Lublin, Poland.
Abstract (Originalsprache)
Dermatophytosis caused by Trichophyton spp. represents a growing public health concern, exacerbated by the increasing prevalence of difficult-to-treat infections and the emergence of resistance to standard antifungal agents, such as terbinafine. In this study, we evaluated the in vitro antifungal activity of a thiosemicarbazide derivative, 1-[(1-methyl-4-nitroimidazol-2-yl)carbonyl]-4-(3-methylphenyl)thiosemicarbazide, against a panel of anthropophilic and zoophilic Trichophyton spp. dermatophytes. Susceptibility testing was performed via the broth microdilution method to determine the minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFCs). The compound demonstrated antifungal efficacy against all the strains tested, with MIC values ranging from 31.25 to 125 µg/mL. Crucially, low MFC/MIC ratios (≤4) confirmed a fungicidal effect, which was further corroborated by microscopic analysis revealing severe hyphal damage in treated dermatophytes. The derivative exhibited consistent activity against both T. rubrum and T. mentagrophytes, including clinical isolates. To our knowledge, this is one of the first detailed evaluations of a nitroimidazole–thiosemicarbazide hybrid against Trichophyton spp. that combines quantitative MIC/MFC testing with morphological assessment. The tested thiosemicarbazide derivative noticeably decreased the viability of VERO and A375 cells, but even at the highest tested concentration, after 72 h of incubation, the cellular viability remained at 65%. These findings suggest that the investigated compound is a promising candidate for the development of new fungicidal drugs or disinfectants for the effective prophylaxis or management of superficial mycoses in human and veterinary medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Microbiology, Medical University of Lublin, Chodzki Str. 1, 20-093 Lublin, Poland.
- Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, Chodzki Str. 4A, 20-093 Lublin, Poland.
- Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, Chodzki Str. 1, 20-093 Lublin, Poland.
ORCID-Profile: Sylwia Andrzejczuk, Monika Wujec, Łukasz Świątek, Urszula Kosikowska
Förderung
- the Medical University of Lublin, Poland
Zitieren
APA
Andrzejczuk, S., Wujec, M., Świątek, Ł., & Kosikowska, U. (2026). Fungicidal Activity of the Nitroimidazole–Thiosemicarbazide Derivative 1-[(1-methyl-4-nitroimidazol-2-yl)carbonyl]-4-(3-methylophenyl)thiosemicarbazide Against Trichophyton spp. Dermatophytes. Pathogens, 15(7), 688. https://doi.org/10.3390/pathogens15070688
Vancouver
Andrzejczuk S, Wujec M, Świątek Ł, Kosikowska U. Fungicidal Activity of the Nitroimidazole–Thiosemicarbazide Derivative 1-[(1-methyl-4-nitroimidazol-2-yl)carbonyl]-4-(3-methylophenyl)thiosemicarbazide Against Trichophyton spp. Dermatophytes. Pathogens. 2026;15(7):688. doi:10.3390/pathogens15070688
BibTeX
@article{Andrzejczuk2026,
author = {Andrzejczuk, Sylwia and Wujec, Monika and Świątek, Łukasz and Kosikowska, Urszula},
title = {Fungicidal Activity of the Nitroimidazole–Thiosemicarbazide Derivative 1-[(1-methyl-4-nitroimidazol-2-yl)carbonyl]-4-(3-methylophenyl)thiosemicarbazide Against Trichophyton spp. Dermatophytes},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {7},
pages = {688},
doi = {10.3390/pathogens15070688}
}
EUVIMED